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filter and reassaying the concentrate. This time the 
inhibition was comparable with that by the whole organism 
or the sonicate. 
The froding of profound acid inhibition by a bacterium 
could possibly be due to non-specific bacterial inhibition by 
a ubiquitous substance such as bacterial lipopolysaccharide. 
To examine this possibility we tested C jejuni, which is an 
organism of comparable morphology, contains cross-
reacting antigens,!3 and is an intestinal pathogen. Since this 
organism had negligible effect on acid secretion we judge 
that such bacterial products are unlikely to be the inhibitory 
factor. Obviously, until a very wide range of bacteria are 
tested in this system, we cannot say whether the inhibition is 
specific to C pylori. We have performed preliminary 
characterisation experiments on the sonicates of the C pylori. 
The inhibitory factor is moderately heat stable, being partly 
inactivated at 60°C for 30 min but completely inhibited by 
boiling for 30 min. Degradation with trypsin, despite 
lengthy incubation, had no effect on the inhibitor. The 
complete elimination of activity by pronase, a less specific 
protease, suggests that the inhibitor is at least in part 
comprised of protein and that inactivation of the protein 
component is required for total loss of activity of the 
inhibitor. Preliminary sizing of the inhibitor by dialysis 
shows that the inhibitor is larger than the molecular weight 
cutoff of the dialysis tubing-12-14000 kD. The 
concentration of the inhibitor is low since 5-fold dilution of 
the sonicate reduces the activity and lO-fold dilution 
abolishes it. This is consistent with the concentration 
needed to see an effect with bacterial supernatants. 
The demonstration of a protein or protein-containing 
acid inhibitor produced by a bacterium raises several 
questions. Why should the effect of the inhibitor eventually 
disappear in most patients, despite continued presence of 
the organism?3 Possible explanations include reduction in 
the bacterial population, a genetic switch-off in the organism 
itself, and an immune response to the inhibitor. The last is 
unlikely in view of the long interval (5-250 days) between 
infection and return to normal acid production. A reduction 
of the extent of bacterial infection is the most likely and will 
require mapping studies of the gastric distribution of the 
organism and its quantitation. 
Presumably, the reduction of acid secretion helps C pylori 
to colonise the stomach. If produced in the local 
environment of the epithelial cell the toxin would not need to 
be secreted in large quantities or be highly potent. The site of 
activity of the inhibitor could be on the apical cell 
membrane, possibly involving the potassium hydrogen 
ATPase. 
Correspondence should be addressed to D. R. C, University Hospital, 
88 East Newton Street, Boston, MA 02118, USA. 
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Summary Plasma endotoxin was measured in 64 
patients undergoing primary liver 
replacement. Endotoxin concentrations increased during 
the anhepatic phase of the operations, and remained high for 
several days. Although the severity of endotoxaemia did not 
correlate with duration of the anhepatic phase, there was a 
correlation between endotoxaemia and the need for 
peri operative platelet transfusions, ventilator dependency 
postoperatively, and one-month case-fatality. 
Introduction 
COMMON complications after orthotopic liver 
transplantation COLT) are coagulopathy, cardiovascular 
instability, respiratory distress syndromes, and multiple 
organ failure; these abnormalities also occur in animals with 
endotoxaemia that have not had a transplant.! 4 Using a 
quantitative blood endotoxin assay,S,6 we have shown a 
correlation between endotoxaemia and pulmonary failure in 
man.7 We have now used this assay to see whether there is an 
association between endotoxaemia after OL T and the 
development of pulmonary complications or thrombo-
cytopenia. 
Patients and Methods 
Patients 
36 men and 28 women (mean age 46 years, range 18-66) had 
primary OL T between March 7 and July 31, 1988. None of the 
patients had had preoperative bacterial infections or massive 
intraoperative bleeding due to technical mishaps. Samples of 
systemic venous blood were collected preoperatively, at the end of 
the anhepatic phase of the operation but before platelet transfusion, 
and on the 1st, 3rd, and 7th postoperative days. The 64 recipients 
were divided into two groups: group A consisted of patients whose 
endotracheal tube could be removed within 5 days (n = 32); group B 
'Present address: First Department of Surgery, Kyushu University, 
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consisted of those who needed longer ventilatory support (30) or 
who died within 5 days (2). 6 patients in group B had a 
retranspJantation within 7 days. The two groups did not differ with 
respect to underlying diseases, medical urgency as judged 
prospectively,8 or age and sex distribution. 3 patients in each group 
were on ventilators preoperatively. 
Platelet replacement during OL T was guided by thrombelasto-
graphic monitoring" In most cases, 1 unit of platelets was given 
with each unit (200 ml) of fresh frozen plasma and 250 ml of 
crystalloids. Platelets were not given until the end of the anhepatic 
phase. 
Endotoxin Assay 
Systemic venous blood was drawn in a pyrogen-free disposable 
syringe, anticoagulated with heparin (10 units/mI), centrifuged 
immediately at 1000 g for 10 min to remove platelets, and stored at 
-80'C. For the colorimetric limulus assay: 0·32 mol/I perchloric 
acid, 0·18 mol/I sodium hydroxide, and 'Toxicolor' (lyophilised 
amoebocyte lysate from Tachypleus tridentatus and synthetic 
chromogenic substrate Boc-Leu-Gly-Arg-p-nitroanilide; 
Seikagaku Kogyo, Tokyo, Japan) with "tris"-hydrochloric acid 
buffer (pH 8·0) were used. The standard curve was plotted with 
Escherichia coli 01l1:B4 endotoxin (Westphal type; Difco 
Laboratories, Detroit, Michigan) in distilled water. The value of 
plasma endotoxin concentrations from 24 healthy volunteers was 
always less than 10 pg/ml. 
Student's t test was used to analyse the data. 
Results 
The mean preoperative endotoxin concentrations of the 
two groups were similar and were within the normal range. 
Intraoperative endotoxaemia developed at the end of the 
anhepatic phase in most of the patients of both groups (fig 1). 
The severity of endotoxaemia did nos correlate with the 
duration of the anhepatic intervals (fig I)--range 41-173 
min, mean 104·8 (SEM 5) for group A and 108·5 (3·7) for 
group B. Endotoxaemia was more severe in group B patients 
who eventually required prolonged ventilatory support (fig 
2). Significant differences between groups A and B were 
maintained for the next 3 days as the endotoxin 
concentration gradually decreased (fig 2). 
43 patients received platelet transfusions because of 
coagulopathy and thrombocytopenia. More transfusions 
were given (intraoperatively and during the next 24 h) to 
patients in group B than to those in group A-mean 13·3 
units (1·8) vs 4·6 (1·0), p < 0·01. There was a positive 
correlation between the number of units transfused and 
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endotoxin concentrations at the end of the anhepatic phase 
(fig 3). 
8 of the 64 patients died within. a month; 7 could not be 
extubated until death. The other patient died suddenly on 
the 11 th postoperative day from rupture of a splenic artery 
aneurysm: convalescence up to this time had been 
satisfactory. Diffuse pulffionary infiltrates developed in 6 of 
the group B patients before death. 
Discussion 
Most of the endotoxin that enters the blood stream is 
detoxified in the liver. 10-12 During the anhepatic phase of 
liver transplantation endotoxin entering the circulation from 
intestinal bacterial flora'O.13,14 or infectious foci can 
accumulate in the blood stream. In laboratory animals 
endotoxaemia leads to a rapid decrease in the number of 
platelets in peripheral blood.4 Thus, the positive correlation 
between the volume of platelet transfusion needed 
perioperatively and the endotoxin concentrations at the end 
of the anhepatic phase in the present study was not 
surprising. Similarly, the correlation of high endotoxin with 
pulmonary complications was as expected from animal 
experiments' -3 and our previous report in human beings.5 
The role of endotoxin' in human disease is poorly 
understood, partly because the lethal dose even in the target 
organs varies with the animal species. '5.16 Additionally, there 
have been difficulties17•18 with the qualitative assay that was 
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previously availab1e.'9 The chromogenic substrate method 
developed by I wanaga et aFo in 1978 paved the way to a 
sensitive quantitative assay of endotoxin. 5,6 Study of patients 
with liver transplants may indicate how endotoxin triggers 
such diverse processes as pulmonary oedema,"3 and also 
shockz and coagulopathy. 4 
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Sumnwry After assessment in mice, a biological 
skin equivalent consisting of cultured 
fibroblasts in a collagen gel overlain with cultured 
keratinocytes was applied to three patients who had had 
tattoos excised. In all patients the grafts took well with good 
cosmetic results and little or no contracture. A biopsy at 4 
weeks showed that the central graft area had a fully 
differentiated epidermis and a mature dermis without 
adnexae. 
INTRODUCTION 
SKIN defects are commonly resurfaced with split-
thickness autografts, which can be expanded in area 
four-fold by meshing' or twenty-fold by dicing into small 
fragments.2 However, harvesting of the split skin leads to 
donor site morbidity, and the skin obtained may be 
inadequate for resurfacing extensive burns. By contrast, 
culture of epidermal keratinocytes to obtain sheets of 
epithelium3 permits almost unlimited expansion. This 
technique has been used successfully in patients with 
extensive burns,' but epithelial grafts are not stable in the 
long term and may give rise to contour defects.5 The 4-week 
lag period between donor skin sampling and the availability 
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of large sheets of keratinocytes may be eliminated by use of 
allografts. There is no need to harvest any skin from the 
recipient if allografts are used, and donor site morbidity is 
therefore eliminated. However, several groups report that 
donor cells do not survive more than a week.lH! Healing 
improves but these grafts are simply acting as sophisticated 
dressings. 
To combine the advantages of massive expansion 
permitted by cultured keratinocyte sheets with the inherent 
stability and cosmetic acceptability of split-thickness skin 
grafts, we have created a skin equivalent. This is a composite 
of cultured keratinocytes and a dermal component which 
displays many features of a normal dermis but is without the 
constituents that would elicit a pronounced immune 
response. The technique was initially assessed in mice, and 
was then applied to patients 
MATERIAL AND METHODS 
Preparation of Skin Equivalent 
Skin biopsy samples 4 nun in diameter were taken urtder local 
anaesthesia from healthy volurtteers and the epidermis and dermis 
were separated with trypsin (2'5 mg/mI in phosphate buffered saline 
with 0·5 nunol/I edetic acid [EDTAJ) overnight at 4°C. The 
keratinocytes were cultured on a feeder layer' and the fibroblasts 
were grown by the method of Ham.' The culture medium was 
Dulbecco's modification of Eagles' medium with 10% fetal calf 
serum (FCS), kanamycin 100 j.lg/mI, amphotericin 1·25 j.lg/mI, 
epidennal growth factor 1·7 nmol/l, hydrocortisone 1·1 J.UTIol/l, and 
cholera toxin 0·1 nmol/l. The dermal equivalent was prepared by 
neutralisation of a 0·5% solution of rat tail collagen'° with a mixture 
of concentrated Eagle's basal medium (x 10) and 0·4 nunol/l 
sodium hydroxide (2:1), and the fibroblasts (IO'/mI) were added 
inunediately before gelling. Keratinocytes were layered onto the 
surface and the cultures were maintained in vitro at 37°C for 4-7 
days. Both fibroblasts andkeratinocytes were derived from the same 
donor. The HLA class I and class II (DR) status of the cultured 
keratinocytes and fibroblasts was assessed with W6/32 and OKT-6 
monoclonal antibodies, respectively; cells were examined on 
coverslip cultures with an indirect inunurtoperoxidase method.ll 
